Why is Memantine Not Recommended in Vascular and Frontotemporal Dementia?

Qutub Jamali

doi:10.4172/dementia.1000129

Journal of Dementia
Open Access

Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

Short Communication
J Dement 2022, Vol 6(4): 129
DOI: 10.4172/dementia.1000129

Why is Memantine Not Recommended in Vascular and Frontotemporal Dementia?

Qutub Jamali^*: Department of Psychiatry and Medical Education, Lancashire & South Cumbria NHS Foundation Trust, United Kingdom

^*Corresponding Author : Qutub Jamali, Department of Psychiatry and Medical Education, Lancashire & South Cumbria NHS Foundation Trust, United Kingdom, Email: qutub.jamali@lancashirecare.nhs.uk

Received Date: Jun 27, 2022 / Accepted Date: Jul 18, 2022 / Published Date: Jul 25, 2022

View PDF Download PDF

Citation: Jamali Q (2022) Why is Memantine Not Recommended in Vascular and Frontotemporal Dementia? J Dement 6: 129. Doi: 10.4172/dementia.1000129

Copyright: © 2022 Jamali Q. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.